AKT1 polymorphisms and survival of early stage non‐small cell lung cancer

This study was conducted to investigate the impact of polymorphisms in the AKT1 gene on the survival of early stage non‐small cell lung cancer (NSCLC) patients.

[1]  H. Jeon,et al.  Polymorphisms in Apoptosis-Related Genes and Survival of Patients with Early-Stage Non-Small-Cell Lung Cancer , 2010, Annals of Surgical Oncology.

[2]  Dong Sun Kim,et al.  Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  L. Tanoue,et al.  The new lung cancer staging system. , 2009, Chest.

[4]  J. Lieberman,et al.  Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia , 2008, Schizophrenia Research.

[5]  Gaetano Rocco,et al.  Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung , 2008, Cell cycle.

[6]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[7]  Xihong Lin,et al.  VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Sheng Li,et al.  Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. , 2007, The Journal of clinical psychiatry.

[9]  D. Neuberg,et al.  MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Miller,et al.  PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer. , 2007, Oncology reports.

[11]  Zhifu Sun,et al.  Gene Expression Profiling on Lung Cancer Outcome Prediction: Present Clinical Value and Future Premise , 2006, Cancer Epidemiology Biomarkers & Prevention.

[12]  T. Asada,et al.  Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia , 2006, Journal of neurochemistry.

[13]  J. Park,et al.  Caspase 9 promoter polymorphisms and risk of primary lung cancer. , 2006, Human molecular genetics.

[14]  A. Levine,et al.  Detection of functional single-nucleotide polymorphisms that affect apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Maier,et al.  Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families , 2005, Biological Psychiatry.

[16]  Y. Miller Pathogenesis of lung cancer: 100 year report. , 2005, American journal of respiratory cell and molecular biology.

[17]  W. Tan,et al.  Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer , 2005, Journal of Medical Genetics.

[18]  Sunil Singhal,et al.  Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review , 2005, Clinical Cancer Research.

[19]  K. O'Byrne,et al.  Phospho-Akt Expression Is Associated with a Favorable Outcome in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[20]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[21]  B. Ponder,et al.  Association of a common variant of the CASP8 gene with reduced risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[22]  M. Ikeda,et al.  Association of AKT1 with schizophrenia confirmed in a Japanese population , 2004, Biological Psychiatry.

[23]  D. Neuberg,et al.  Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy , 2004, Clinical Cancer Research.

[24]  A. Loktionov Common gene polymorphisms, cancer progression and prognosis. , 2004, Cancer letters.

[25]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[26]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[27]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[28]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[29]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[30]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[31]  P. Dennis,et al.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.

[32]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[33]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[34]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[35]  J. Minna,et al.  Molecular genetics of lung cancer. , 1988, Annual review of medicine.

[36]  G. Viglietto,et al.  Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. , 2008, Cell cycle.

[37]  J. Testa,et al.  Activation of AKT kinases in cancer: implications for therapeutic targeting. , 2005, Advances in cancer research.

[38]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.